Skip to content

Omega 3 as an adujunct to conventional non surgical therapy in chronic periodontitis

Scaling and root planing with or without omega 3 supplimentation in management of chronic periodontitis a comparative study - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/088500
Enrollment
30
Registered
2025-06-10
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K053- Chronic periodontitis

Interventions

Intervention1: Scaling and root planing: Management of chronic periodontitis patients with scaling and root planing alone Control Intervention1: Omega 3 supplement: Management of chronic periodontitis

Sponsors

Dr Sankha Subhra Roy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patient with generalized chronic periodontitis 2 Age 18 to 65 years 3 Male and female both 4 Moderate chronic periodontitis patients 5 Co-operative motivated and patients committed to maintain oral hygiene

Exclusion criteria

Exclusion criteria: 1 Smoking 2 Pregnant and lactating females 3 Any known allergies and hypersensitivity to any of the products used in this trial 4 Any systemic diseases that impact bone density and results of periodontal therapy 5 Patients receiving any medication known to have periodontal effects that could impede wound healing including those on long term systemic therapy

Design outcomes

Primary

MeasureTime frame
Management of chronic periodontitis with scaling and root planing with or without omega 3 supplementationTimepoint: Baseline 3 months 6 months

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Sankha Subhra Roy

Maharishi markandeshwar college of dental sciences and research

rajeshguptafzk@gmail.com09501142575

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026